National Organization for Women (NOW)

For Immediate Release

Contact: 

Elise Coletta, elise@now.org, (951) 547-1241

NOW Welcomes FDA Decision on Women's HSDD Treatment

Statement of NOW President Terry O'Neill

WASHINGTON - The Food and Drug Administration did the right thing by approving the first-ever medical treatment for women’s most common sexual complaint and we hope that other safe and effective treatments will be approved. Hypoactive Sexual Desire Disorder (HSDD) is a serious condition experienced by about ten percent of pre-menopausal women, yet it has taken seven years for this drug, Flibanserin (Addyi), to get the green-light.

The National Organization for Women insists on the right of women with HSDD to be taken seriously and to have treatment options that improve their health and quality of life.

Women – no less than men – deserve to have satisfactory sexual experiences and fulfilling intimate relationships.

View this statement online by clicking here.

###

This is the world we live in. This is the world we cover.

Because of people like you, another world is possible. There are many battles to be won, but we will battle them together—all of us. Common Dreams is not your normal news site. We don't survive on clicks. We don't want advertising dollars. We want the world to be a better place. But we can't do it alone. It doesn't work that way. We need you. If you can help today—because every gift of every size matters—please do.

The National Organization for Women (NOW) is the largest organization of feminist activists in the United States. NOW has 500,000 contributing members and 550 chapters in all 50 states and the District of Columbia.

Share This Article